EICHORPublic-registry site landscape for NCT05026164, “Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity”, a Delayed Onset Muscle Soreness (DOMS) study sponsored by Canopy Growth Corporation. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05026164 (registry record) |
| Study title | Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Repeated-Dose Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity |
| Sponsor | Canopy Growth Corporation |
| Condition(s) | Delayed Onset Muscle Soreness (DOMS) |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT05026164.
Eichor generates a preliminary site-risk snapshot for NCT05026164 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
More from Canopy Growth Corporation
← Eichor home · All tracked trials · Delayed Onset Muscle Soreness (DOMS) studies · Weekly briefs
